CLB - Core Laboratories N.V.
NYSE
->
Energy
->
Oil & Gas Equipment & Services
Amstelveen,
Netherlands
Type: Equity
CLB price evolution
CLB
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.7 | $14.91 | $15.12 | $16.62 |
| Short term investments | ||||
| Net receivables | $115.64 | $115.09 | $109.35 | $104.05 |
| Inventory | $69.9 | $70.71 | $71.7 | $75.06 |
| Total current assets | $233.53 | $229.05 | $222.97 | $228.54 |
| Long term investments | ||||
| Property, plant & equipment | $154.2 | $152.16 | $153.47 | $152.6 |
| Goodwill & intangible assets | $106.12 | $106.25 | $106.37 | $106.72 |
| Total noncurrent assets | $364.27 | $358.9 | $363.26 | $363.87 |
| Total investments | ||||
| Total assets | $597.8 | $587.95 | $592.6 | $592.41 |
| Current liabilities | ||||
| Accounts payable | $36.86 | $32.49 | $33.51 | $34.1 |
| Deferred revenue | $5.5 | $5.13 | $4.75 | $4.64 |
| Short long term debt | $11.04 | $10.43 | $10.18 | $9.79 |
| Total current liabilities | $97.6 | $85.47 | $87.47 | $84.25 |
| Long term debt | $190.24 | $201.85 | $163.13 | $218.77 |
| Total noncurrent liabilities | $254.51 | $265.06 | $268.49 | $278.71 |
| Total debt | $201.28 | $212.28 | $215.38 | $228.56 |
| Total liabilities | $352.11 | $350.53 | $358.53 | $362.96 |
| Shareholders' equity | ||||
| Retained earnings | $132.07 | $123.51 | $120.76 | $119.02 |
| Other shareholder equity | -$5.31 | -$5.16 | $234.07 | -$3.84 |
| Total shareholder equity | $240.27 | $232.16 | $224.81 | $224.69 |
| (in millions $) | 31 Jan 2025 | 31 Jan 2024 | 31 Jan 2023 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $15.12 | $15.43 | $17.7 | |
| Short term investments | ||||
| Net receivables | $109.35 | $106.91 | $96.83 | |
| Inventory | $71.7 | $60.45 | $45.44 | |
| Total current assets | $222.97 | $211.7 | $189.06 | |
| Long term investments | ||||
| Property, plant & equipment | $153.47 | $157.41 | $172.34 | |
| Goodwill & intangible assets | $106.37 | $106.93 | $107.58 | |
| Total noncurrent assets | $363.26 | $366.65 | $391.8 | |
| Total investments | ||||
| Total assets | $592.6 | $578.35 | $580.85 | |
| Current liabilities | ||||
| Accounts payable | $33.51 | $45.85 | $29.73 | |
| Deferred revenue | $4.75 | $5.94 | $7.76 | |
| Short long term debt | $10.18 | $11.7 | $12.34 | |
| Total current liabilities | $87.47 | $103.14 | $90.78 | |
| Long term debt | $163.13 | $172.39 | $237.92 | |
| Total noncurrent liabilities | $268.49 | $286.26 | $329.07 | |
| Total debt | $215.38 | $222.39 | $250.26 | |
| Total liabilities | $358.53 | $389.4 | $419.85 | |
| Shareholders' equity | ||||
| Retained earnings | $120.76 | $85.95 | $68.35 | |
| Other shareholder equity | $234.07 | $188.95 | -$10.13 | |
| Total shareholder equity | $224.81 | $184.26 | $156.45 | |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $130.58 | $129.64 | $128.21 | |
| Cost of revenue | $102.93 | $104.59 | ||
| Gross Profit | $27.65 | $25.05 | $26.69 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $10.26 | $11.79 | ||
| Total operating expenses | $11.64 | $16.48 | $12.11 | |
| Operating income | $16.01 | $8.57 | ||
| Income from continuing operations | ||||
| EBIT | $15.85 | $8.3 | ||
| Income tax expense | $3.61 | $1.66 | $4.26 | |
| Interest expense | $3.21 | $3.42 | -$3.62 | |
| Net income | ||||
| Net income | $9.03 | $3.22 | $6.46 | |
| Income (for common shares) | $9.03 | $3.22 | ||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Jan 2022 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $489.74 | $487.27 | ||
| Cost of revenue | $393.65 | $374.77 | ||
| Gross Profit | $96.08 | $112.5 | ||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $38.12 | $34.03 | ||
| Total operating expenses | $54.56 | $189.31 | ||
| Operating income | $41.52 | -$76.81 | ||
| Income from continuing operations | ||||
| EBIT | $41.32 | -$77.37 | ||
| Income tax expense | $10.3 | $5.9 | ||
| Interest expense | $11.57 | $14.37 | ||
| Net income | ||||
| Net income | $19.45 | -$97.64 | ||
| Income (for common shares) | $19.45 | -$97.64 | ||
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
|---|---|---|---|---|
| Net income | $9.03 | $3.22 | $9.26 | |
| Operating activities | ||||
| Depreciation | $3.77 | $3.84 | $3.93 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | -$0.13 | $4.82 | $2.07 | |
| Total cash flows from operations | $17.15 | $5.53 | -$0.21 | |
| Investing activities | ||||
| Capital expenditures | -$2.66 | -$2.46 | -$3.39 | |
| Investments | ||||
| Total cash flows from investing | -$0.69 | -$1.66 | -$6.65 | -$3.39 |
| Financing activities | ||||
| Dividends paid | -$0.47 | -$0.47 | -$1.87 | -$0.47 |
| Sale and purchase of stock | -$0.16 | -$0.04 | -$0.22 | |
| Net borrowings | -$12.98 | -$3.02 | -$5.25 | |
| Total cash flows from financing | -$13.68 | -$4.08 | -$18.45 | -$5.99 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $2.78 | -$0.21 | -$0.31 | -$9.59 |
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $19.45 | $19.73 | -$97.64 | |
| Operating activities | ||||
| Depreciation | $17.16 | $18.52 | $20.87 | |
| Business acquisitions & disposals | $0.24 | $0.87 | -$0.23 | |
| Stock-based compensation | $7.76 | $19.09 | $7.39 | |
| Total cash flows from operations | $24.96 | $36.58 | $57.87 | |
| Investing activities | ||||
| Capital expenditures | -$8.36 | -$13.18 | -$10.64 | |
| Investments | ||||
| Total cash flows from investing | -$6.65 | -$3.86 | -$10.22 | $7.85 |
| Financing activities | ||||
| Dividends paid | -$1.87 | -$1.85 | -$1.83 | -$12.45 |
| Sale and purchase of stock | -$3.9 | $51.74 | -$2.79 | |
| Net borrowings | -$17.21 | -$71 | -$46 | |
| Total cash flows from financing | -$18.45 | -$23.38 | -$22.46 | -$63.01 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$0.31 | -$2.27 | $3.9 | $2.71 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.39 |
| Quick ratio | 1.68 |